Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12848365rdf:typepubmed:Citationlld:pubmed
pubmed-article:12848365lifeskim:mentionsumls-concept:C0446221lld:lifeskim
pubmed-article:12848365lifeskim:mentionsumls-concept:C0002168lld:lifeskim
pubmed-article:12848365lifeskim:mentionsumls-concept:C1011943lld:lifeskim
pubmed-article:12848365lifeskim:mentionsumls-concept:C0039421lld:lifeskim
pubmed-article:12848365lifeskim:mentionsumls-concept:C0027607lld:lifeskim
pubmed-article:12848365lifeskim:mentionsumls-concept:C0332256lld:lifeskim
pubmed-article:12848365lifeskim:mentionsumls-concept:C0015399lld:lifeskim
pubmed-article:12848365pubmed:issue1lld:pubmed
pubmed-article:12848365pubmed:dateCreated2003-7-9lld:pubmed
pubmed-article:12848365pubmed:abstractTextEye drops made of aloe are a sterile, aqueous extract of fresh leaves of Aloe arborescens Mill., containing necessary additives and neomycin sulphate. The aim of the studies was to establish the technology of eye drops containing biologically active aloe substances and those containing both chemical constituents of aloe and neomycin sulphate. Within the studies, the formulary content and the way of preparing eye drops were determined, criteria were defined and methods of qualitative assessment of drops were proposed. On the basis of the proposed analytical methods, the physicochemical and microbiological stability of the eye drops stored at a temperature of 20-25 degrees C was studied. As the criteria of qualitative assessment of the eye drops, the following analyses were considered: sterility, appearance of the eye drops (clarity), pH, osmotic pressure, density, viscosity, TLC analysis, content of aloenin and aloin, studies of anti-microbial activity of neomycin in the drops, and preservative efficiency of thiomersal in the eye drops. The studies showed that the additives such as: sodium chloride, benzalkonium chloride, chlorhexidine diacetate and digluconate, phenylmercuric borate and Nipagins M and P could not be used to prepare the eye drops because they were involved in pharmaceutical interactions with chemical constituents of aloe in the eye drops. The eye drops containing: aqueous extract of fresh leaves of aloe, boric acid, thiomersal, sodium pyrosulphite, disodium EDTA, beta-phenylethyl alcohol and neomycin sulphate, both freshly prepared and after two years of storage, met the requirements of the Polish Pharmacopoeia (PPh V) mentioned in the monograph Guttae ophthalmicae. They were sterile, clear, their osmotic pressure approximated the osmotic pressure of lacrimal fluid and they were characterized by appropriate pH. Aloenin in the drops was much more stable than aloin. Neomycin after two years of storage retained almost 98% of its starting antimicrobial activity which allows the conclusion that the biologically active aloe substances did not decrease the stability of neomycin in the drops. The preservation assay showed that thiomersal, both in the freshly prepared drops and after two years of storage, maintained antimicrobial activity, which was in accordance with PPh V.lld:pubmed
pubmed-article:12848365pubmed:languageenglld:pubmed
pubmed-article:12848365pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12848365pubmed:citationSubsetIMlld:pubmed
pubmed-article:12848365pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12848365pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12848365pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12848365pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12848365pubmed:statusMEDLINElld:pubmed
pubmed-article:12848365pubmed:issn0001-6837lld:pubmed
pubmed-article:12848365pubmed:authorpubmed-author:MarcinkowskiA...lld:pubmed
pubmed-article:12848365pubmed:authorpubmed-author:KodymAAlld:pubmed
pubmed-article:12848365pubmed:authorpubmed-author:Kuku?aHHlld:pubmed
pubmed-article:12848365pubmed:issnTypePrintlld:pubmed
pubmed-article:12848365pubmed:volume60lld:pubmed
pubmed-article:12848365pubmed:ownerNLMlld:pubmed
pubmed-article:12848365pubmed:authorsCompleteYlld:pubmed
pubmed-article:12848365pubmed:pagination31-9lld:pubmed
pubmed-article:12848365pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:12848365pubmed:meshHeadingpubmed-meshheading:12848365...lld:pubmed
pubmed-article:12848365pubmed:meshHeadingpubmed-meshheading:12848365...lld:pubmed
pubmed-article:12848365pubmed:meshHeadingpubmed-meshheading:12848365...lld:pubmed
pubmed-article:12848365pubmed:meshHeadingpubmed-meshheading:12848365...lld:pubmed
pubmed-article:12848365pubmed:meshHeadingpubmed-meshheading:12848365...lld:pubmed
pubmed-article:12848365pubmed:meshHeadingpubmed-meshheading:12848365...lld:pubmed
pubmed-article:12848365pubmed:meshHeadingpubmed-meshheading:12848365...lld:pubmed
pubmed-article:12848365pubmed:meshHeadingpubmed-meshheading:12848365...lld:pubmed
pubmed-article:12848365pubmed:meshHeadingpubmed-meshheading:12848365...lld:pubmed
pubmed-article:12848365pubmed:meshHeadingpubmed-meshheading:12848365...lld:pubmed
pubmed-article:12848365pubmed:articleTitleTechnology of eye drops containing aloe (Aloe arborescens Mill.--Liliaceae) and eye drops containing both aloe and neomycin sulphate.lld:pubmed
pubmed-article:12848365pubmed:affiliationDepartment of Drug Form Technology, Ludwik Rydygier Medical University in Bydgoszcz.lld:pubmed
pubmed-article:12848365pubmed:publicationTypeJournal Articlelld:pubmed